Vimala Raghavendran is Vice President of Informatics Product Development at the US Pharmacopeia, a non-profit organization that sets quality standards for medicines in the US. Vimala’s role involves building digital products that leverage USP’s proprietary datasets and methods. In the last 4 years, Vimala led the creation of the USP Medicine Supply Map, a dataset that identifies, characterizes and predicts risk in the US medicine supply. The USP Medicine Supply Map is used by buyers, manufacturers and federal agencies to prioritize medicines vulnerable to drug shortages and quickly size risk when there is a shock to the supply chain. Vimala has been quoted in several publications, including the NY Times, CNN and Financial Times and has testified in Congress as a drug shortage expert. Vimala’s portfolio also focuses on lab informatics products that enable bench scientists to execute USP test methods. Prior to this role, Vimala led a multinational team responsible for strategy and analytics at USP. She spent four years as a strategy consultant / manager at McKinsey and Co., where she focused on pharma, payor and provider clients. She has also worked in market research and fundraising at a non-profit biotech. She has an MBA (Healthcare) from the Wharton School at the University of Pennsylvania and a BA in Economics from Knox College. Vimala is based in Washington, DC.